These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15251373

  • 21. Influence of albumin supplementation on tacrolimus and cyclosporine therapy early after liver transplantation.
    Trull A, Hughes V, Cooper D, Wilkins M, Gimson A, Friend P, Johnston A, Sharples L, Park G.
    Liver Transpl; 2002 Mar; 8(3):224-32. PubMed ID: 11910567
    [Abstract] [Full Text] [Related]

  • 22. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study.
    Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, Bonaccorsi-Riani E, Vanthuyne V, Hetsch N, Roggen F, Reyck CD, Goffette P, Latinne D, Orlando G, Rahier J, Sempoux C, Wallemacq P, Laterre PF, Gianello P.
    Ann Surg; 2008 Dec; 248(6):956-67. PubMed ID: 19092340
    [Abstract] [Full Text] [Related]

  • 23. Adverse effects on the lipid profile of immunosuppressive regimens: tacrolimus versus cyclosporin measured using C2 levels.
    Sánchez Pérez B, Aranda Narváez JM, Suárez Muñoz MA, Fernández Aguilar JL, González Sánchez AJ, Pérez Daga JA, Santoyo Santoyo J.
    Transplant Proc; 2009 Apr; 41(3):1028-9. PubMed ID: 19376418
    [Abstract] [Full Text] [Related]

  • 24. Randomized clinical trial of tacrolimus- vs cyclosporine-based immunosuppression in pediatric heart transplantation: preliminary results at 15-month follow-up.
    Pollock-Barziv SM, Dipchand AI, McCrindle BW, Nalli N, West LJ.
    J Heart Lung Transplant; 2005 Feb; 24(2):190-4. PubMed ID: 15701436
    [Abstract] [Full Text] [Related]

  • 25. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR, Lin CC, Lian JD.
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [Abstract] [Full Text] [Related]

  • 26. Tacrolimus conversion improves hyperlipidemic states in stable liver transplant recipients.
    Manzarbeitia C, Reich DJ, Rothstein KD, Braitman LE, Levin S, Munoz SJ.
    Liver Transpl; 2001 Feb; 7(2):93-9. PubMed ID: 11172391
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE, El-Dahshan K, Mahmoud K, Ismail AM, El-Baz M, Shokeir AA, Ghoneim MA.
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [Abstract] [Full Text] [Related]

  • 29. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M, Haddad H, Leblanc MH, Giannetti N, Pflugfelder P, Davies R, Isaac D, Burton J, Chan M, Azevedo E, Howlett J, Ignaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H.
    J Heart Lung Transplant; 2005 Jul; 24(7):798-809. PubMed ID: 15982605
    [Abstract] [Full Text] [Related]

  • 30. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients.
    Kobashigawa JA, Patel J, Furukawa H, Moriguchi JD, Yeatman L, Takemoto S, Marquez A, Shaw J, Oeser BT, Subherwal S, Wu GW, Kawano J, Laks H.
    J Heart Lung Transplant; 2006 Apr; 25(4):434-9. PubMed ID: 16563974
    [Abstract] [Full Text] [Related]

  • 31. Arterial elasticity measurement in renal transplant patients under anticalcineurin immunosuppression.
    Martínez-Castelao A, Sarrias X, Bestard O, Gil-Vernet S, Serón D, Cruzado JM, Moreso F, Díez-Noguera A, Grinyó JM.
    Transplant Proc; 2005 Nov; 37(9):3788-90. PubMed ID: 16386539
    [Abstract] [Full Text] [Related]

  • 32. Arterial hypertension in liver transplant recipients.
    Hryniewiecka E, Zegarska J, Paczek L.
    Transplant Proc; 2011 Oct; 43(8):3029-34. PubMed ID: 21996217
    [Abstract] [Full Text] [Related]

  • 33. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
    Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J.
    J Hepatol; 2006 Apr; 44(4):717-22. PubMed ID: 16487616
    [Abstract] [Full Text] [Related]

  • 34. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Fukuhara N, Ono Y, Hattori R, Nishiyama N, Yamada S, Kamihira O, Kinukawa T, Ohshima S.
    Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
    [Abstract] [Full Text] [Related]

  • 35. Blood pressure and graft outcome in renal transplantation.
    Berber I, Aydin C, Yigit B, Kara VM, Yildar M, Duzyol C, Turkmen F, Titiz MI, Altaca G.
    Transplant Proc; 2005 Mar; 37(2):997-8. PubMed ID: 15848602
    [Abstract] [Full Text] [Related]

  • 36. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
    Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C.
    Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
    [Abstract] [Full Text] [Related]

  • 37. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral.
    Wang CH, Ko WJ, Chou NK, Wang SS.
    Transplant Proc; 2004 Oct; 36(8):2386-7. PubMed ID: 15561257
    [Abstract] [Full Text] [Related]

  • 38. A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
    Kim SJ, Prasad GV, Huang M, Nash MM, Famure O, Park J, Thenganatt MA, Chowdhury N, Cole EH, Fenton SS, Cattran DC, Zaltzman JS, Cardella CJ.
    Transplantation; 2006 Oct 15; 82(7):924-30. PubMed ID: 17038908
    [Abstract] [Full Text] [Related]

  • 39. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.
    Strózecki P, Adamowicz A, Włodarczyk Z, Manitius J.
    Ren Fail; 2007 Oct 15; 29(6):679-84. PubMed ID: 17763162
    [Abstract] [Full Text] [Related]

  • 40. Predominance of nocturnal hypertension in pediatric renal allograft recipients.
    McGlothan KR, Wyatt RJ, Ault BH, Hastings MC, Rogers T, DiSessa T, Jones DP.
    Pediatr Transplant; 2006 Aug 15; 10(5):558-64. PubMed ID: 16856991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.